Skandinaviska Enskilda Banken Ab (Publ) Cerus Corp Transaction History

Skandinaviska Enskilda Banken Ab (Publ)

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 10, 2022	SELL	$4.41 - $5.69 $119,259 - $153,874	-27,043 Reduced 23.83%	86,453 $457,000
Q1 2022 May 11, 2022	SELL	$4.81 - $6.99 $270,995 - $393,816	-56,340 Reduced 33.17%	113,496 $623,000
Q3 2021 Nov 10, 2021	BUY	$4.79 - $6.68 $251,580 - $350,846	52,522 Added 44.77%	169,836 $1.03 Million
Q2 2021 Aug 10, 2021	BUY	$5.35 - $6.35 $18,591 - $22,066	3,475 Added 3.05%	117,314 $693,000
Q1 2021 May 14, 2021	BUY	$5.68 - $7.87 $33,869 - $46,928	5,963 Added 5.53%	113,839 $684,000
Q4 2020 Feb 11, 2021	BUY	$5.25 - $8.56 $93,675 - $152,736	17,843 Added 19.82%	107,876 $747,000
Q3 2020 Nov 12, 2020	BUY	$5.78 - $7.47 $508,645 - $657,367	88,001 Added 4330.76%	90,033 $564,000
Q2 2020 Aug 13, 2020	BUY	$4.5 - $7.02 $9,144 - $14,264	2,032 New	2,032 $13,000

156

147M

84.2K

55.5K

Ticker CERS
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 177,090,000
Market Cap $312M
Description
Cerus Corporation operates as a biomedical products company. The company focuses on developing and commercializing the INTERCEPT Blood System to enhance blood safety. Its INTERCEPT Blood System, a proprietary technology for controlling biological replication that is designed to reduce blood-borne pathogens in donated blood components intended fo...

Get notified when there are updates to the investment portfolio of Skandinaviska Enskilda Banken Ab (Publ), based on Form 13F filings with the SEC.

Stay updated on Skandinaviska Enskilda Banken Ab (Publ) with notifications on news.